Suppr超能文献

使用肝细胞/DNA修复试验对甲吡咯啉及相关抗组胺药潜在遗传毒性的研究。

A study of the potential genotoxicity of methapyrilene and related antihistamines using the hepatocyte/DNA repair assay.

作者信息

Budroe J D, Shaddock J G, Casciano D A

出版信息

Mutat Res. 1984 Feb;135(2):131-7. doi: 10.1016/0165-1218(84)90166-6.

Abstract

Methapyrilene and four related antihistamines were evaluated for their ability to cause DNA repair measured autoradiographically as unscheduled DNA synthesis (UDS) in primary cultures of Fischer-344 rat hepatocytes. Methapyrilene failed to induce UDS at all doses tested while pyrilamine and tripelennamine induced a concentration-dependent increase in DNA repair. Doxylamine and thenyldiamine, previously untested in this system, induced a weak response at the highest non-toxic doses tested. Methapyrilene was clearly cytotoxic at doses of 100 microM and higher, as judged by morphology, and precursor incorporation into RNA and protein. Precursor incorporation into RNA was irreversibly inhibited 90% and 55% at 1000 microM and 100 microM methapyrilene, respectively, while precursor incorporation into protein was inhibited 80% and 60%. These data verify the genotoxicity of pyrilamine and tripelennamine and the failure of methapyrilene to elicit DNA repair, and suggest that doxylamine and thenyldiamine may be weak DNA-damaging agents.

摘要

对甲吡咯啉和四种相关的抗组胺药进行了评估,以测定它们在Fischer-344大鼠肝细胞原代培养物中引起DNA修复的能力,DNA修复通过放射自显影法测定为非预定DNA合成(UDS)。在所测试的所有剂量下,甲吡咯啉均未能诱导UDS,而吡苄明和曲吡那敏诱导了DNA修复的浓度依赖性增加。多西拉敏和噻吩二胺此前未在此系统中进行测试,在测试的最高无毒剂量下诱导了微弱反应。从形态学以及前体掺入RNA和蛋白质的情况判断,甲吡咯啉在100微摩尔及更高剂量时具有明显的细胞毒性。在1000微摩尔和100微摩尔甲吡咯啉时,前体掺入RNA分别被不可逆地抑制了90%和55%,而前体掺入蛋白质被抑制了80%和60%。这些数据证实了吡苄明和曲吡那敏的遗传毒性以及甲吡咯啉未能引发DNA修复,并表明多西拉敏和噻吩二胺可能是弱DNA损伤剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验